Adenosine A2A receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats

European Journal of Pharmacology

Volumn 464, Issue 1, 2003, Pages 33-38

  Corsi, Claudia ^a   Pinna, Annalisa ^b   Gianfriddo, Marco ^a   Melani, Alessia ^a   Morelli, Micaela ^b   Pedata, Felicita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Adenosine A2A receptor; Glutamate; Microdialysis; Parkinson's disease; Striatum

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; DOPAMINE; GLUTAMIC ACID; ADENOSINE RECEPTOR; OXIDOPAMINE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DIALYSATE; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; CORPUS STRIATUM; DENERVATION; DOPAMINE; GLUTAMIC ACID; MALE; MICRODIALYSIS; OXIDOPAMINE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; TIME FACTORS; TRIAZOLES;

EID: 0038323958     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01352-9     Document Type: Article

References (25)

1. Abarca J., Bustos G. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway. Neurochem. Int. 35:1999;19-33.
2. Ascherio A., Zhang S.M., Hernan M.A., Kawachi I., Colditz G.A., Speizer F.E., Willett W.C. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann. Neurol. 50:2001;56-63.
3. Bianchi L., Della C.L., Tipton K.F. Simultaneous determination of basal and evoked output levels of aspartate, glutamate, taurine and 4-aminobutyric acid during microdialysis and from superfused brain slices. J. Chromatogr., B, Biomed. Sci. Appl. 723:1999;47-59.
4. 2A and D2 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98:2001;1970-1975.
5. +-evoked glutamate release in vivo in young and aged rats. NeuroReport. 10:1999;687-691.
6. 2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. NeuroReport. 11:2000;2591-2595.
7. Dixon A.K., Gubitz A.K., Sirinathsinghji D.J., Richardson P.J., Freeman T.C. Tissue distribution of adenosine receptor mRNAs in the rat. Br. J. Pharmacol. 118:1996;1461-1468.
8. 2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 321:1997;143-147.
9. 2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U. S. A. 88:1991;7238-7241.
10. 2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res. 14:1992;186-195.
11. Gevaerd M.S., Takahashi R.N., Silveira R., Da Cunha C. Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats. Brain Res. Bull. 55:2001;101-106.
12. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog. Neurobiol. 56:1998;507-540.
13. 2-selective agonist, [3H]CGS 21680. Eur. J. Pharmacol. 168:1989;243-246.
14. Jonkers N., Sarre S., Ebinger G., Michotte Y. MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats. Brain Res. 926:2002;149-155.
15. 2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys. Ann. Neurol. 43:1998;507-513.
16. Marsden C.D. Basal ganglia disease. Lancet. 2:1982;1141-1147.
17. Meshul C.K., Emre N., Nakamura C.M., Allen C., Donohue M.K., Buckman J.F. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience. 88:1999;1-16.
18. Olah M.E., Stiles G.L. The role of receptor structure in determining adenosine receptor activity. Pharmacol. Ther. 85:2000;55-75.
19. Paxinos G., Watson G. The Rat Brain in Stereo-Taxic Coordinates. 1982;Academic Press, New York.
20. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A Stereotaxic Atlas of the Rat Brain. 1979;Plenum, New York.
21. 2A receptor mRNA by dopamine denervation. Eur. J. Pharmacol. 446:2002;75-82.
22. Popoli P., Betto P., Rimondini R., Reggio R., Pezzola A., Ricciarello G., Fuxe K., Ferre S. Age-related alteration of the adenosine/dopamine balance in the rat striatum. Brain Res. 795:1998;297-300.
23. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
24. 2A receptors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1856-1860.
25. Waddington J.L. Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT. Pharmacol. Biochem. Behav. 13:1980;915-917.